ATLANTA , April 29, 2014 /PRNewswire/ -- First Quarter Highlights:
Grew HeRO ® Graft revenues 26 percent year-over-year to $1.6 million Received FDA approval to begin PerClot ® clinical trial Received FDA 510(k) clearance for PerClot Topical Secured distribution rights and purchase option for ProCol ® Vascular Bioprosthesis Established new regional headquarters in Singapore to expand presence in rapidly growing Asia-Pacific medical device market CryoLife, Inc. (NYSE: CRY) , a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today its results for the first quarter of 2014.
CHICAGO, IL --
- First Quarter 2014 GAAP Earnings Per Diluted Share of $0.55 - - 86% Increase in First Quarter 2014 Adjusted EBITDA to $860 million - DUBLIN , April 30, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today reported net revenue increased 40 percent to $2.66 billion for the first quarter ended March 31, 2014 , compared to $1.90 billion in the first quarter 2013.
REDWOOD SHORES, Calif., May 6, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Model N, Inc. (NYSE: MODN) , the leader in revenue management solutions, announced the recipients of the Rainmaker Awards at its tenth-annual Global Revenue Management Summit in Savannah, Georgia.
REDWOOD SHORES, Calif., May 14, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Model N, Inc. (NYSE: MODN) , a leading revenue management solutions provider to the life science and technology industries, and Salix Pharmaceuticals (NASDAQ: SLXP) , a leading specialty pharmaceutical manufacturer, today announced that Salix is live on the latest release of Model N's Revenue Management suite.
REDWOOD CITY, Calif., April 23, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Model N, Inc. (NYSE:MODN) , the leading Revenue Management solutions provider, today announced the immediate availability of two applications, REVVY CPQ, REVVY Global Price Management, on the Salesforce1 AppExchange, empowering businesses to connect with customer, partners and employees in a whole new way.
PLEASANTON, CA --
LAS VEGAS, NV and PLEASANTON, CA --
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.